Atopic Dermatitis Eczema Clinical Trial
Official title:
Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on Real-world Data Collection With a Smartphone Application and a Validated Actigraphy Wristband
Atopic dermatitis is a chronic disease with a high impact on patient's quality of life. Nocturnal pruritus is one of the main symptoms affecting quality of life. Treatment efficacy is generally measured by healthcare professionals during consultations with both questioning and visual examination of the lesions. Quality of Life (QoL) can also be evaluated retrospectively with the Dermatology Life Quality Index (DLQI) scale. Collecting data retrospectively introduces a significant recall bias that can be addressed by collecting data in Real World (RW). Real World data collection is prospective and take place within the patient's own environment. While data collection is generally done with diaries, it has been demonstrated that smartphone and connected devices were able to produce more precise and granular data than traditional methods.
The main objective of the study is to demonstrate a medical hypothesis using a wristband
actigraph: patients with moderate to severe atopic dermatitis have a poorer quality and
quantity of sleep than healthy subject.
Secondary objetives are to assess the interest of a smartphone application in evaluating the
quality of life of patients with moderate to severe atopic dermatitis in regard of those of
healthy volunteers.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05579899 -
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
|
Phase 2 | |
| Terminated |
NCT04085549 -
Effects of a Berry Oil Cream on Atopic Eczema and Skin
|
N/A | |
| Recruiting |
NCT05578482 -
Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis
|
Phase 4 | |
| Completed |
NCT03540043 -
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT03293030 -
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
|
Phase 4 | |
| Completed |
NCT03386032 -
8-Week Atopic Dermatitis (AD) Treatment Study
|
Phase 3 | |
| Completed |
NCT03667014 -
The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
|
Phase 4 | |
| Terminated |
NCT05382819 -
A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
|
Phase 1 | |
| Completed |
NCT04537468 -
Development of a Method to Measure mRNA Levels in Skin Samples
|
N/A | |
| Completed |
NCT03268174 -
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
|
N/A | |
| Active, not recruiting |
NCT03859986 -
Study in Subjects With Moderate Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT04800185 -
Characterizing Skin Microbiome Change in Atopic Dermatitis
|
Early Phase 1 | |
| Completed |
NCT06361992 -
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children
|
Phase 3 | |
| Recruiting |
NCT06024499 -
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
|
Phase 2 | |
| Recruiting |
NCT03742414 -
Seal, Stopping Eczema and Allergy Study
|
Phase 2 | |
| Not yet recruiting |
NCT06454942 -
Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals
|
N/A | |
| Recruiting |
NCT05935085 -
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
|
Phase 2 | |
| Recruiting |
NCT03795506 -
TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)
|
N/A | |
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
||
| Not yet recruiting |
NCT06469385 -
Topical ENS-002 for Atopic Dermatitis in Adults
|
Phase 1 |